Candidiasis in the intensive care unit

Area of Science:

• Medical Mycology
• Infectious Diseases
• Critical Care Medicine

Background:

• Candida species have emerged as significant opportunistic pathogens in intensive care units (ICUs).
• Nosocomial infections caused by Candida are increasingly prevalent, particularly in critically ill patients.
• Superficial candidiasis can be refractory to standard antifungals, while invasive infections carry high mortality rates.

Purpose of the Study:

• To review the evolving landscape of Candida infections in ICUs.
• To highlight the challenges posed by non-albicans Candida species and antifungal resistance.
• To discuss emerging therapeutic strategies for invasive candidiasis.

Main Methods:

• Literature review of epidemiological trends in Candida infections.
• Analysis of antifungal susceptibility patterns.
• Evaluation of current and novel treatment options for invasive candidiasis.

Main Results:

• Increasing incidence of Candida infections in ICUs, with a rise in non-albicans species.
• Emerging resistance to azole antifungals in certain Candida strains.
• Development of effective treatments including lipid formulations of amphotericin B and echinocandins.

Conclusions:

• Invasive candidiasis in ICUs presents significant therapeutic challenges due to increasing incidence and antifungal resistance.
• Lipid formulations of amphotericin B and echinocandins provide crucial treatment options.
• Continued surveillance and development of new antifungal agents are essential for managing Candida infections.